Professional
Added to YB: 2024-10-25
Pitch date: 2024-09-30
ILMN [bullish]
Illumina, Inc.
+3.6%
current return
Author Info
No bio for this author
Company Info
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
Market Cap
$18.4B
Pitch Price
$130.18
Price Target
N/A
Dividend
N/A
EV/EBITDA
15.81
P/E
27.05
EV/Sales
4.60
Sector
Life Sciences Tools and Services
Category
turnaround
Artisan Mid Cap Fund Added On Portfolio Holding: Illumina, Inc.
ILMN: Leading next-gen sequencing provider. Post-Grail spin-off, new mgmt focuses on cost control & sustainable growth. Expanding from research to clinical diagnostics as genome sequencing costs fall. Stock price undervalues unique life science tools franchise. Building Garden position despite recent challenges.
Read full article (1 min)